The global smart insulin pens and pumps market size was valued at USD 4.81 billion in 2025 and is projected to grow from USD 5.28 billion in 2026 to USD 11.16 billion by 2034 at a CAGR of 9.8% during the forecast period 2026-2034. North America dominated the smart insulin pens and pumps market with a market share of 39.8% in 2025.
Smart insulin pens and pumps are advanced diabetes management devices designed to make insulin therapy more convenient, personalized, and easier to monitor. These technologies can help patients deliver insulin more accurately while reducing the burden of managing daily injections or continuous insulin delivery. Smart pens may record dosing information and connect with mobile applications, allowing users and healthcare professionals to track insulin use and make informed treatment decisions.
Insulin pumps, meanwhile, deliver insulin continuously through a wearable device and can work alongside glucose monitoring systems to support better diabetes management. As digital healthcare continues to develop, smart insulin devices are gaining attention for their potential to improve treatment adherence, simplify routine care, and support more connected approaches to diabetes management.
Download a Free Sample To learn more about this report,
The smart insulin pens and pumps market is moving toward connected, automated, and data-driven diabetes care. Devices are increasingly being integrated with continuous glucose monitors and smartphone applications to support more personalized insulin delivery and monitoring. Automated insulin delivery is also expanding beyond traditional type 1 diabetes use. In August 2024, the U.S. FDA expanded the indication of Insulet’s SmartAdjust technology to adults with type 2 diabetes, supporting broader adoption of automated insulin management. The trend is also shifting toward interoperable devices that can communicate with other digital health technologies, improving convenience and reducing the daily burden of diabetes management.
The growing need for better diabetes management is a major driver of adoption of smart insulin pens and pumps. The World Health Organization reported in 2024 that more than 800 million adults worldwide were living with diabetes, highlighting the large and expanding need for effective treatment solutions. Connected insulin devices can help automate insulin delivery, reduce manual tasks, and support more consistent glucose management when used with compatible monitoring systems. Regulatory progress is also encouraging innovation and broader access. In 2024, the FDA expanded automated insulin dosing technology to adults with type 2 diabetes, opening a new user group for advanced insulin delivery systems.
High costs, affordability concerns, technical complexity, and dependence on reliable digital connectivity can limit the wider adoption of smart insulin pens and pumps. The WHO emphasized in its 2025 report that diabetes technologies need to be available, affordable, safe, and of good quality, showing that access remains an important issue. Smartphone-connected devices can also create safety concerns when users miss critical alerts because of phone settings or software changes. In February 2025, the FDA warned that missed alerts from connected diabetes devices had been associated with serious events, including severe hypoglycemia, hyperglycemia, diabetic ketoacidosis, and death.
The market has strong opportunities in automated insulin delivery, connected healthcare, and broader use among people with type 2 diabetes. Integration between insulin pumps, continuous glucose monitors, mobile applications, and automated dosing software can create more seamless diabetes management. The expansion of regulatory approvals into new patient groups also provides room for manufacturers to develop easier-to-use systems. Emerging markets represent another opportunity as healthcare systems improve access to diabetes technologies. The WHO’s Global Diabetes Compact aims to improve access to affordable insulin and blood glucose self-monitoring, supporting long-term demand for better diabetes management tools and related technologies.
Safety, reliability, cybersecurity, interoperability, and user training remain important challenges for smart insulin pens and pumps. These devices often depend on software, sensors, smartphones, and wireless connections, creating additional points where technical problems can affect insulin delivery or safety alerts. Recent regulatory actions also show the importance of continuous device monitoring. In 2025, the FDA published safety information concerning corrections involving certain Tandem insulin pumps, including issues that could interrupt insulin delivery. Such events can affect patient confidence and increase the need for stronger quality controls and post-market surveillance. Manufacturers must balance advanced functionality with simple operation and dependable performance.
Request Customizationto receive a tailored report.
The disposable pens segment leads the smart insulin pens and pumps market with a market share of 39.6%, while insulin pumps are the fastest-growing segment, recording a CAGR of 11.42%. Disposable pens remain popular because they offer convenience, ease of use, and simple insulin administration, making them suitable for patients who prefer straightforward treatment options. Reusable pens are also gaining attention as they provide flexibility and can support long-term diabetes management. Meanwhile, insulin pumps are witnessing strong growth due to their ability to provide continuous insulin delivery and support more personalized diabetes care. Increasing awareness of advanced insulin management technologies, growing diabetes prevalence, and integration with digital health systems are contributing to demand across product categories.
The hospitals and clinics segment dominates the smart insulin pens and pumps market with a market share of 56.3%, while the others segment is the fastest-growing category, registering a CAGR of 11.83%. Hospitals and clinics play an important role in diabetes diagnosis, treatment, insulin therapy, and patient monitoring, supporting their leading position in the market. The use of smart insulin delivery devices in clinical settings can help healthcare professionals manage patients more effectively and support personalized treatment plans. Diagnostic laboratories also contribute to market demand by supporting diabetes testing and monitoring. Meanwhile, the growth of the others segment reflects increasing adoption of smart insulin technologies across alternative healthcare and care settings as awareness of connected diabetes management continues to improve.
The hospital pharmacy segment holds the largest share of the smart insulin pens and pumps market at 38.4%, while online channels are emerging as the fastest-growing segment with a CAGR of 13.72%. Hospital pharmacies remain an important distribution channel because patients can access insulin delivery products through healthcare facilities where treatment and medical guidance are available. Retail pharmacies also play a significant role by offering convenient access to diabetes management products for patients who require regular supplies. At the same time, online channels are gaining momentum as consumers increasingly prefer convenient purchasing options and home delivery. The expansion of digital healthcare services, improved e-commerce accessibility, and growing consumer familiarity with online medical product purchasing are supporting the growth of this distribution channel.
Speak to an Analystto discuss market opportunities.
North America dominates the smart insulin pens and pumps market with a 39.8% market share and a value of USD 1.91 billion. The region benefits from advanced healthcare infrastructure, strong adoption of digital health technologies, and growing demand for convenient diabetes management solutions. The United States and Canada are key markets, supported by increasing use of connected insulin devices and glucose monitoring technologies. Rising awareness of personalized diabetes care and continuous innovation in insulin delivery systems are also supporting regional growth.
The United States is a leading market due to its advanced healthcare infrastructure and strong adoption of innovative diabetes management technologies. Growing use of connected insulin pens, pumps, and glucose monitoring systems is supporting demand. The presence of major healthcare technology companies and increasing interest in personalized treatment are also creating favorable conditions for smart insulin device adoption.
Canada is supported by a well-developed healthcare system and increasing interest in technology-enabled diabetes care. Patients and healthcare professionals are showing growing demand for convenient insulin management solutions. The adoption of connected medical devices, digital health platforms, and personalized treatment approaches is creating opportunities for smart insulin pens and pumps across the country.
Europe is the fastest-growing region in the smart insulin pens and pumps market, recording a CAGR of 12.18%, while holding a 28.6% market share and a value of USD 1.38 billion. Growth is supported by increasing adoption of digital healthcare, advanced diabetes management technologies, and connected medical devices. Germany and the United Kingdom are important markets, where healthcare providers are increasingly focusing on personalized and technology-enabled diabetes care. Growing patient awareness and continued innovation in insulin delivery systems are further supporting regional market development.
Germany is an important European market, supported by advanced healthcare infrastructure and strong capabilities in medical technology. Growing interest in digital healthcare and connected diabetes management is encouraging the adoption of smart insulin delivery devices. Patients are increasingly seeking convenient treatment solutions, while healthcare professionals are exploring technologies that can support better diabetes management and personalized care.
The United Kingdom is witnessing increasing interest in smart insulin pens and pumps as digital healthcare becomes more integrated into diabetes management. Connected insulin devices can help patients manage their daily treatment more conveniently while supporting healthcare professionals with useful treatment information. Growing awareness of personalized diabetes care and technology-enabled healthcare is creating favorable opportunities for market development.
Asia Pacific holds a 22.4% market share with a value of USD 1.08 billion and a CAGR of 11.64%. The region is benefiting from increasing diabetes awareness, expanding healthcare infrastructure, and rising adoption of digital health technologies. Japan and China are important markets, supported by growing interest in advanced medical devices and connected healthcare solutions. Increasing demand for convenient insulin delivery and personalized diabetes management is encouraging the use of smart insulin technologies. Continued healthcare modernization and technological development are expected to create further opportunities across the region.
Japan is an important market supported by its advanced healthcare system and strong technological capabilities. The country has a growing focus on innovative solutions for chronic disease management, creating opportunities for smart insulin pens and pumps. Increasing interest in connected healthcare, digital monitoring, and personalized diabetes treatment is encouraging the adoption of advanced insulin delivery technologies among patients and healthcare providers.
China offers significant opportunities for smart insulin technologies due to expanding healthcare services and growing awareness of diabetes management. Digital health adoption is increasing as patients and healthcare professionals seek more convenient treatment solutions. Smart insulin pens and pumps can support easier insulin administration and technology-enabled monitoring. Continued healthcare development and rising interest in advanced medical devices are expected to support market adoption.
The Middle East and Africa region accounts for a 4.1% market share and a value of USD 0.2 billion, with a CAGR of 7.95%. The market is gradually developing as healthcare infrastructure improves and awareness of advanced diabetes management increases. The UAE is an important market, supported by investments in healthcare modernization and digital transformation. Growing adoption of innovative medical technologies and connected healthcare solutions is creating opportunities for smart insulin pens and pumps. Increasing focus on improving chronic disease management is also supporting regional interest in advanced insulin delivery systems.
The UAE is an emerging market supported by modern healthcare infrastructure and a strong focus on digital healthcare transformation. Healthcare providers are increasingly exploring advanced technologies for chronic disease management and patient care. Smart insulin pens and pumps can support convenient insulin administration and connected diabetes management. Growing access to modern medical services, increasing awareness of diabetes technologies, and the country's focus on healthcare innovation are creating favorable conditions for the adoption of smart insulin delivery solutions.
Latin America holds a 5.1% market share and a value of USD 0.25 billion, with a CAGR of 8.72%. The region is gradually adopting advanced diabetes management technologies as healthcare awareness and access to modern treatment solutions improve. Brazil is a key market, supported by its large healthcare sector and growing interest in digital health. Increasing awareness of connected medical devices and demand for convenient insulin management are creating opportunities for smart insulin pens and pumps. Improvements in healthcare services and patient education are also expected to support wider adoption of technology-enabled diabetes care.
Brazil is an important Latin American market with growing interest in advanced diabetes management and digital healthcare technologies. Patients and healthcare professionals are increasingly exploring solutions that can make insulin administration more convenient and support personalized treatment. Smart insulin pens and pumps can benefit from rising awareness of connected medical devices and technology-enabled healthcare. Continued improvements in healthcare access, digital health adoption, and awareness of modern diabetes management approaches are creating opportunities for smart insulin technologies in the country.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com